Earnings Performance - UnitedHealth Group reported quarterly earnings of $7 15 per share, beating the Zacks Consensus Estimate of $7 02 per share, representing a 1 85% earnings surprise [1] - The company's earnings increased from $6 56 per share a year ago, with adjusted figures for non-recurring items [1] - Over the last four quarters, the company has consistently surpassed consensus EPS estimates [1] Revenue Growth - UnitedHealth posted revenues of $100 82 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 1 31% [1] - This represents an increase from year-ago revenues of $92 36 billion [1] - The company has topped consensus revenue estimates in each of the last four quarters [1] Stock Performance - UnitedHealth shares have gained approximately 15% since the beginning of the year, underperforming the S&P 500's gain of 22 9% [2] - The stock's immediate price movement will depend on management's commentary during the earnings call [2] Earnings Outlook - The current consensus EPS estimate for the coming quarter is $6 92 on $101 67 billion in revenues [4] - For the current fiscal year, the consensus EPS estimate is $27 68 on $399 71 billion in revenues [4] - The estimate revisions trend for UnitedHealth was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) [4] Industry Context - The Medical - HMOs industry, to which UnitedHealth belongs, is currently in the bottom 6% of the Zacks industries [5] - The top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [5] - The Joint Corp, another company in the same industry, is expected to report quarterly earnings of $0 04 per share, representing a year-over-year change of +180% [5]

UNITEDHEALTH GR UnitedHealth Group Reports Third Quarter 2024 Results | --- | --- | --- | |-------|-------|----------------------------------------------------------------------| | | | • Revenues of $100.8 Billion Grew $8.5 Billion Year | | | | Over Year | | | | • Consumers Served by UnitedHealthcare's | | | | Commercial Domestic Offerings Grew 2.4 Million | | | | Year to Date | | | | • Third Quarter Earnings of $6.51 Per Share Include | | | | Cyberattack Impacts | | | | • Adjusted Earnings of $7.15 Per Sha ...

Analyst Estimates for Q3 2024 Q2 2024 Q3 2023Revenue$99.3 billion$98.86 billion$92.36 billionDiluted EPS$6.66$4.54$6.24Net Income$6.16 billion$4.22 billion$5.84 billion Key Metric: Optum Revenue Last quarter, revenue from UnitedHealth's Optum division jumped 11.7% year-over-year to $62.9 billion as it added more patients at Optum Health and raised the number of customers using its Optum Rx pharmacy service.  Analysts expect $63.7 billion this quarter, which would represent a 12% increase. The number of O ...

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Kindly note that our content on Seeking Alpha and other platforms doesn't constitute financial advice ...

CHINA - 2024/09/06: In this photo illustration, the UnitedHealth Group logo is displayed on the ... [+] screen of a smartphone. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesUnitedHealth Group (NYSE: UNH) is scheduled to report its Q2 2024 results on Tuesday, October 15. We expect UnitedHealth to post revenue of $99 billion and earnings of $6.95 on a per-share and adjusted basis, slightly below the street expectations. The company will ...

Analysts on Wall Street project that UnitedHealth Group (UNH) will announce quarterly earnings of $7.02 per share in its forthcoming report, representing an increase of 7% year over year. Revenues are projected to reach $99.55 billion, increasing 7.8% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals ...

UnitedHealth Group Incorporated (UNH) is set to report third-quarter 2024 results on Oct. 15, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $7.02 per share on revenues of $99.6 billion. Growing premiums, commercial memberships and Optum business are expected to have supported its performance, partially affected by elevated expenses and lower Medicaid memberships.Stay up-to-date with all quarterly releases: See Zacks Earnings Cale ...

In the latest trading session, UnitedHealth Group (UNH) closed at $583.56, marking a -1.29% move from the previous day. This change lagged the S&P 500's 0.96% loss on the day. Elsewhere, the Dow lost 0.94%, while the tech-heavy Nasdaq lost 1.18%.Shares of the largest U.S. health insurer have depreciated by 0.95% over the course of the past month, outperforming the Medical sector's loss of 3.69% and lagging the S&P 500's gain of 4.3%.Analysts and investors alike will be keeping a close eye on the performance ...

The most recent trading session ended with UnitedHealth Group (UNH) standing at $584.68, reflecting a +0.49% shift from the previouse trading day's closing. The stock's performance was ahead of the S&P 500's daily gain of 0.42%. Meanwhile, the Dow gained 0.04%, and the Nasdaq, a tech-heavy index, added 0.38%. The the stock of largest U.S. health insurer has fallen by 1.41% in the past month, leading the Medical sector's loss of 2.49% and undershooting the S&P 500's gain of 2.06%. The investment community wi ...

With the Federal Trade Commission (FTC) taking a scalpel to the pharmacy benefit managers (PBMs) of UnitedHealth Group Inc UNH, CVS Health Corp CVS and Cigna Group CI, investors are left wondering which health giant can best weather the storm.The FTC's lawsuit, targeting these companies for allegedly inflating insulin prices, could have a major ripple effect across the healthcare industry—and that means stock volatility. So, which stock looks healthier?UnitedHealth Group: Big & Bold, But Under The Microscop ...